Sharp Services

United States
Packaging & Labeling Sterile Fill-Finish
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (14) ○ Clinical Trials ○ SEC Filings ✓ Press (6) ○ EMA GMP ✓ MHRA GMP (2) ✓ HC GMP (19)

Quick Facts: Sharp Services

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
United States
Website
Modalities
Packaging & Labeling, Sterile Fill-Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Sharp Services

Sharp Services is a contract development and manufacturing organization (CDMO). Capabilities: Packaging & Labeling, Sterile Fill-Finish. 3 manufacturing sites registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.sharpservices.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Sharp Services FDA Inspection History

2026-04
2026-03
2026-02
2025-11
2025-09
2024-08
2024-06
2023-08
2023-02
2023-01
2022-12
2022-09
2022-01
2021-10
NAI VAI OAI
Date Site Type Observations Classification
2026-04-22
Sharp Packaging Services, LLC
Allentown, Pennsylvania Company-level
Vaccines and Allergenic Products No No Action Indicated (NAI)
2026-03-05
Sharp Sterile Manufacturing, LLC
Lee, Massachusetts Company-level
Drug Quality Assurance Yes Official Action Indicated (OAI)
2026-02-06
Sharp Packaging Services, LLC
Conshohocken, Pennsylvania Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2025-11-21
Sharp Packaging Services, LLC
Allentown, Pennsylvania Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2025-09-12
Sharp Packaging Services, LLC
Macungie, Pennsylvania Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2024-08-29
Sharp Clinical Services, LLC
Bethlehem, Pennsylvania Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2024-06-12
Sharp Sterile Manufacturing, LLC
Lee, Massachusetts Company-level
Human Cellular, Tissue, and Gene Therapies Yes Voluntary Action Indicated (VAI)
2023-08-25
Sharp Sterile Manufacturing, LLC
Lee, Massachusetts Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-02-24
Sharp Packaging Services, LLC
Conshohocken, Pennsylvania Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2023-01-20
Sharp Sterile Manufacturing, LLC
Lee, Massachusetts Company-level
Blood and Blood Products No Voluntary Action Indicated (VAI)
2022-12-09
Sharp Packaging Services, LLC
Macungie, Pennsylvania Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2022-09-02
Sharp Clinical Services, LLC
Bethlehem, Pennsylvania Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2022-01-28
Sharp Packaging Services, LLC
Allentown, Pennsylvania Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2021-10-15
Sharp Sterile Manufacturing, LLC
Lee, Massachusetts Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 01, 2026

Sharp Services FDA 483 Findings 31 observations · 2021-10-15 → 2026-03-05 ?

By subsystem

  • Documentation & Records 8 (25.8%)
  • Other 7 (22.6%)
  • Equipment & Facilities 7 (22.6%)
  • CAPA 4 (12.9%)
  • Laboratory Controls 2 (6.5%)
  • Environmental Monitoring 2 (6.5%)
  • Personnel & Training 1 (3.2%)

By severity

  • 4 — Serious: 2
  • 3 — Moderate: 6
  • 2 — Minor: 23
  • Repeat observations: 3

Most severe findings

  • Serious (4) Environmental Monitoring 2026-03-05 21 CFR 211.42(c)(10)(v)
    Cleaning System

    "Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room to produce aseptic conditions."

  • Serious (4) Environmental Monitoring 2021-10-15 21 CFR 211.42(c)(10)(v)
    Cleaning System

    "Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions."

  • Moderate (3) CAPA 2026-03-05 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed."

Sharp Services MHRA GMP Compliance 2 certificates

2025-11
2025-11
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK MIA 10284 Insp GMP/IMP 10284/18457585-0016[H] SHARP CLINICAL SERVICES (UK) LIMITED TREDEGAR NP22 5RL 2025-11-04 COMPLIANT
UK MIA(IMP) 10284 Insp GMP/IMP 10284/18457585-0016[I] SHARP CLINICAL SERVICES (UK) LIMITED TREDEGAR NP22 5RL 2025-11-04 COMPLIANT
Source: MHRA GMDP Database · Retrieved Nov 01, 2026

Japan-accredited overseas site (PMDA)

cell and gene therapy (CGT), general (non-sterile), packaging/storage only, registration only · 4 sites

  • Allentown, United States · Sharp Packaging Services, LLC — general (non-sterile), packaging/storage only · valid to Mar 30, 2030
  • Bethlehem, United States · Sharp Clinical Services, LLC — registration only · valid to Nov 4, 2029
  • Conshohocken, United States · Sharp Packaging Services, LLC — general (non-sterile) · valid to Dec 15, 2029
  • Lee, United States · Sharp Sterile Manufacturing, LLC — cell and gene therapy (CGT) · valid to Jun 5, 2030

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity 64 open roles Beta

From public job postings on Sharp Services' careers board, as of Oct 31, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
64
open roles
49
in manufacturing, quality, PD/MSAT, engineering or regulatory (77%)
Trend from Nov 29, 2026
Tracking started Oct 30, 2026. 30-day change shows after 30 days, 90-day after Jan 28, 2027.
Since Oct 30, 2026: 0 new postings, 0 taken down.
What this may mean
  • 8 manufacturing and operations openings at Macungie. That fits staffing of production shifts; on its own it doesn't show new capacity.
By function
Manufacturing & operations 35
Quality (QA / QC) 8
Engineering & facilities 6
Commercial, BD & client projects 8
Other (finance, HR, IT, other) 7
By site
Allentown
17 mfg/ops · 2 QA/QC · 4 eng. · 13 other
36
Macungie
8 mfg/ops · 2 QA/QC
10
Bethlehem
6 mfg/ops · 3 QA/QC
9
Conshohocken
4 mfg/ops · 1 QA/QC · 1 eng. · 2 other
8
Hamont Achel
· 1 eng.
1
Latest postings
Supply Chain Specialist Manufacturing & operations · Conshohocken
Supervisor, Operations 3rd Shift Manufacturing & operations · Macungie
Supervisor, Operations 1st Shift Manufacturing & operations · Allentown
Supervisor, Operations Manufacturing & operations · Conshohocken
Serialization and Electrical Engineer Engineering & facilities · Allentown
Senior Validation Engineer Quality (QA / QC) · Macungie
Senior Serialization and Technical Services Specialist Other (finance, HR, IT, other) · Allentown
Senior Project Engineer Engineering & facilities · Allentown
Senior Estimator Other (finance, HR, IT, other) · Conshohocken
Quality Packaging Associate II, 2nd Shift Manufacturing & operations · Allentown
Quality Packaging Associate II, 1st Shift Manufacturing & operations · Allentown
Quality Assurance Specialist Quality (QA / QC) · Bethlehem
Coverage: counted from Sharp Services' own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: sharpservices.wd3.myworkdayjobs.com · Checked Oct 31, 2026 · Tracking since Oct 30, 2026

Company Signals 6 articles

Company announcements, not verified evidence. They do not change any score.
news Thu, 30 Oc
Dr. Adriana Kiędzierska-Mencfeld Named Woman of the Year at CPHI Frankfurt - Contract Pharma
news Thu, 23 Oc
Lonza expects more CDMO contracts; Galderma’s $650M US commitment - Endpoints News
news Thu, 08 Ja
Sharp Sterile Manufacturing invests $28m into US sterile fill-finish site - Manufacturing Chemist
news Thu, 05 Oc
Sharp expands partnership with buyout of CDMO Berkshire Sterile Manufacturing - Fierce Pharma
news Thu, 05 Oc
Sharp Acquires Berkshire Sterile Manufacturing - BioPharm International
news Fri, 24 Oc
Sharp Services to Invest $100M Across Global Facility Network - Contract Pharma

Frequently Asked Questions About Sharp Services

How many FDA inspections does Sharp Services have on record?
CDMO Signal tracks 14 FDA inspections for Sharp Services, sourced from the FDA inspection database. See the full inspection history above.
Has Sharp Services received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Sharp Services.
Does Sharp Services hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 MHRA GMP certificates for Sharp Services.
Does Sharp Services have a CDMO Signal Score?
Not yet. Sharp Services is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Sharp Services for a manufacturing program?
Use the free AI matchmaker to compare Sharp Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

James Alexander Corporation
United States
Sterile Fill-Finish, Packaging & Labeling
PCI Pharma Services
Bedford, NH, United States · Tredegar, United Kingdom
Sterile Fill-Finish, Biologics, Oral Solid Dose, Clinical Trial Manufacturing, Packaging & Labeling
Argonaut Manufacturing Services
Carlsbad, California, USA
Sterile Fill-Finish, Packaging & Labeling
Rechon Life Science
Malmö, Sweden
Sterile Fill-Finish, Prefilled Syringes, Inhalation & Nasal, Packaging & Labeling
Saptalis Pharmaceuticals
Hauppauge, New York, USA
Oral Liquids, Semi-solids & Liquids, Topicals, Sterile Fill-Finish, Packaging & Labeling

Compare Sharp Services with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Sharp Services
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.